Loading…
This event has ended. Visit the official site or create your own event on Sched.

View analytic
Wednesday, June 29 • 10:30am - 11:30am
#327: FDA–Health Canada Regulatory Cooperation Council Town Hall

Sign up or log in to save this to your schedule and see who's attending!

Limited Capacity seats available

Component Type: Session
Level: Intermediate
CE: CME 1.00; IACET 1.00; RN 1.00

The Regulatory Cooperation Council (RCC) was created in 2011 to develop smarter and more efficient and effective approaches to regulatory cooperation. FDA and Health Canada will highlight their work under RCC phase 2 and request stakeholder input on their current initiatives.

Learning Objectives

Discuss FDA and Health Canada Regulatory Cooperation Council (RCC) priority areas over the next two years; Identify areas for stakeholders to contribute to the RCC process.

Chair

Sema D. Hashemi, MSc

Speaker

Panelist
Sema D. Hashemi, MSc

Panelist
Ed Morgan



Chair
SH

Sema Hashemi

Director, Office of Regional and Country Affairs, FDA
Ms. Sema Hashemi is currently employed with the U.S. Food and Drug Administration serving as Deputy Director, Asia-Pacific Office in the Office of International Programs.

Speakers
avatar for Ed Morgan

Ed Morgan

Director General, Policy, Planning and International Affairs Directorate, HPFB, Health Canada
In this position, Ed oversees regulatory policy development for health products and food, and provides strategic advice on advancing horizontal health policy and international agendas. Before joining Health Canada, Ed was Director of Operations for the Operations Committee of Cabinet at the Privy Council Office. Prior to, he was Chief of Staff to the Deputy Clerk of the Privy Council, and has held various other positions over the years in the... Read More →


Wednesday June 29, 2016 10:30am - 11:30am
201C Pennsylvania Convention Center 1101 Arch Street, Philadelphia, PA 19107 USA